The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
The Dualistic Model of Ovarian Carcinogenesis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
WHO classification of tumours of female reproductive organs
Kurman, R. J., Carcangiu, M. L., Herrington, C. S., & Young, R. H. (2014) · International Agency for Research on Cancer eBooks · Cited by 1,966
Self-citationARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Self-citationWhole–genome characterization of chemoresistant ovarian cancer
Patch, A.-M., Christie, E. L., Etemadmoghadam, D., Garsed, D. W., George, J., Fereday, S., Nones, K., Cowin, P., Alsop, K., Bailey, P. J., et al. (2015) · Nature · doi:10.1038/nature14410 · Cited by 1,569
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
Tothill, R. W., Tinker, A. V., George, J., Brown, R., Fox, S. B., Lade, S., Johnson, D. S., Trivett, M. K., Etemadmoghadam, D., Locandro, B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0196 · Cited by 1,467
Buys, S. S. (2011) · JAMA · doi:10.1001/jama.2011.766 · Cited by 1,323
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T.-L., Shih, I.-M., Mao, T.-L., Nakayama, K., Roden, R., Glas, R., Slamon, D., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,219
Self-citationShih, I.-M., & Kurman, R. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63708-x · Cited by 1,206
Self-citationKindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,113
Pennington, K. P., Walsh, T., Harrell, M. I., Lee, M. K., Pennil, C. C., Rendi, M. H., Thornton, A., Norquist, B. M., Casadei, S., Nord, A. S., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2287 · Cited by 1,051
Jacobs, I. J., Menon, U., Ryan, A., Gentry-Maharaj, A., Burnell, M., Kalsi, J. K., Amso, N. N., Apostolidou, S., Benjamin, E., Cruickshank, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01224-6 · Cited by 1,048
Medeiros, F., Muto, M. G., Lee, Y., Elvin, J. A., Callahan, M. J., Feltmate, C., Garber, J. E., Cramer, D. W., & Crum, C. P. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000180854.28831.77 · Cited by 916
Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma
Singer, G., Oldt, R., Cohen, Y., Wang, B. G., Sidransky, D., Kurman, R. J., & Shih, I.-M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.484 · Cited by 854
Self-citationCollaborative Group on Epidemiological Studies of Ovarian Cancer (2008) · The Lancet · doi:10.1016/s0140-6736(08)60167-1 · Cited by 822
Piek, J. M. J., van Diest, P. J., Zweemer, R. P., Jansen, J. W., Poort‐Keesom, R. J. J., Menko, F. H., Gille, J. J. P., Jongsma, A. P. M., Pals, G., Kenemans, P., et al. (2001) · The Journal of Pathology · doi:10.1002/path.1000 · Cited by 787
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
Bitler, B. G., Aird, K. M., Garipov, A., Li, H., Amatangelo, M., Kossenkov, A. V., Schultz, D. C., Liu, Q., Shih, I.-M., Conejo-Garcia, J. R., et al. (2015) · Nature Medicine · doi:10.1038/nm.3799 · Cited by 678
Self-citationBlaustein’s Pathology of the Female Genital Tract
(2011) · Springer eBooks · doi:10.1007/978-1-4419-0489-8 · Cited by 668
Perets, R., Wyant, G. A., Muto, K. W., Bijron, J. G., Poole, B. B., Chin, K. T., Chen, J. Y. H., Ohman, A. W., Stepule, C. D., Kwak, S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.013 · Cited by 596
Liu, J. F., Barry, W. T., Birrer, M., Lee, J.-M., Buckanovich, R. J., Fleming, G. F., Rimel, B., Buss, M. K., Nattam, S., Hurteau, J., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70391-2 · Cited by 585
ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
Shen, J., Peng, Y., Wei, L., Zhang, W., Yang, L., Lan, L., Kapoor, P., Ju, Z., Mo, Q., Shih, I.-M., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0849 · Cited by 522 · cited 1×
“More recently, preclinical studies have found that type I tumors harboring ARID1A mutations are more sensitive to the treatment with the use of EZH2 inhibitor(101) and polyADP ribose polymerase (PARP) inhibitor.(102) Although type II tumors are initially chemosensitive, as a result of their highly proliferative activi…”
BackgroundSelf-citationDankort, D., Filenova, E., Collado, M., Serrano, M., Jones, K., & McMahon, M. (2007) · Genes & Development · doi:10.1101/gad.1516407 · Cited by 481
Parker, W. H., Feskanich, D., Broder, M. S., Chang, E., Shoupe, D., Farquhar, C. M., Berek, J. S., & Manson, J. E. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182864350 · Cited by 454
Sato, N., Tsunoda, H., Nishida, M., Morishita, Y., Takimoto, Y., Kubo, T., & Noguchi, M. (2000) · PubMed · doi:10.11501/3187985 · Cited by 448
Ovarian Cancer Risk After Salpingectomy: A Nationwide Population-Based Study
Falconer, H., Yin, L., Gronberg, H., & Altman, D. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju410 · Cited by 436
Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
Przybycin, C. G., Kurman, R. J., Ronnett, B. M., Shih, I.-M., & Vang, R. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181ef7b16 · Cited by 410
Self-citationPrognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
Konecny, G. E., Wang, C., Hamidi, H., Winterhoff, B., Kalli, K. R., Dering, J., Ginther, C., Chen, H.-W., Dowdy, S., Cliby, W., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju249 · Cited by 398
Kuhn, E., Kurman, R. J., Vang, R., Sehdev, A. S., Han, G., Soslow, R., Wang, T., & Shih, I. (2012) · The Journal of Pathology · doi:10.1002/path.3023 · Cited by 387
Self-citationEvaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.
Kinde, I., Bettegowda, C., Wang, Y., Wu, J., Agrawal, N., Shih, I.-M., Kurman, R., Dao, F., Levine, D. A., Giuntoli, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004952 · Cited by 327
Self-citationLongacre, T. A., McKenney, J. K., Tazelaar, H. D., Kempson, R. L., & Hendrickson, M. R. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000164030.82810.db · Cited by 323
Chandler, R. L., Damrauer, J. S., Raab, J. R., Schisler, J. C., Wilkerson, M. D., Didion, J. P., Starmer, J., Serber, D., Yee, D., Xiong, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms7118 · Cited by 323
Wu, R., Hendrix-Lucas, N., Kuick, R., Zhai, Y., Schwartz, D. R., Akyol, A., Hanash, S., Misek, D. E., Katabuchi, H., Williams, B. O., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.016 · Cited by 313
McAlpine, J. N., Hanley, G. E., Woo, M. M. M., Tone, A. A., Rozenberg, N., Swenerton, K. D., Gilks, C. B., Finlayson, S. J., Huntsman, D. G., & Miller, D. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.01.003 · Cited by 286
Serous Carcinogenesis in the Fallopian Tube: A Descriptive Classification
Jarboe, E., Folkins, A., Nucci, M. R., Kindelberger, D., Drapkin, R., Miron, A., Lee, Y., & Crum, C. P. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31814b191f · Cited by 273
Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma
Soslow, R. A., Han, G., Park, K. J., Garg, K., Olvera, N., Spriggs, D. R., Kauff, N. D., & Levine, D. A. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.183 · Cited by 262
Kato, M., Paranjape, T., Ullrich, R., Nallur, S., Gillespie, E., Keane, K., Esquela-Kerscher, A., Weidhaas, J. B., & Slack, F. J. (2009) · Oncogene · doi:10.1038/onc.2009.106 · Cited by 240
Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
Mok, S. C., Bell, D. A., KNAPP, R. C., Fishbaugh, P. M., Welch, W. R., Muto, M. G., Berkowitz, R. S., & Tsao, S. (1993) · PubMed · Cited by 237
Mayr, D., Hirschmann, A., Löhrs, U., & Diebold, J. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.05.029 · Cited by 224
Grisham, R. N., Iyer, G., Garg, K., DeLair, D., Hyman, D. M., Zhou, Q., Iasonos, A., Berger, M. F., Dao, F., Spriggs, D. R., et al. (2013) · Cancer · doi:10.1002/cncr.27782 · Cited by 221
BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas
Wong, K.-K., Tsang, Y. T. M., Deavers, M. T., Mok, S. C., Zu, Z., Sun, C., Malpica, A., Wolf, J. K., Lu, K. H., & Gershenson, D. M. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100212 · Cited by 220
Low‐grade serous carcinomas of the ovary contain very few point mutations
Jones, S., Wang, T., Kurman, R. J., Nakayama, K., Velculescu, V. E., Vogelstein, B., Kinzler, K. W., Papadopoulos, N., & Shih, I. (2012) · The Journal of Pathology · doi:10.1002/path.3967 · Cited by 218
Self-citationHelland, Å., Anglesio, M. S., George, J., Cowin, P. A., Johnstone, C. N., House, C. M., Sheppard, K. E., Etemadmoghadam, D., Melnyk, N., Rustgi, A. K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018064 · Cited by 215
Mutations of BRAF and KRAS Precede the Development of Ovarian Serous Borderline Tumors
Ho, C.-L., Kurman, R. J., Dehari, R., Wang, T.-L., & Shih, I.-M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2067 · Cited by 206
Self-citationKuo, K.-T., Guan, B., Feng, Y., Mao, T.-L., Chen, X., Jinawath, N., Wang, Y., Kurman, R. J., Shih, I.-M., & Wang, T.-L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3913 · Cited by 196
Self-citationSequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms
Nakayama, K., Nakayama, N., Kurman, R. J., Cope, L., Pohl, G., Samuels, Y., Velculescu, V. E., Wang, T.-L., & Shih, I.-M. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.7.2751 · Cited by 187
Self-citationCatasús, L., Bussaglia, E., Rodrı́guez, I., Gallardo, A., Pons, C., Irving, J. A., & Prat, J. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.07.019 · Cited by 181
Visvanathan, K., Vang, R., Shaw, P., Gross, A., Soslow, R., Parkash, V., Shih, I.-M., & Kurman, R. J. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31822f58bc · Cited by 177
Self-citationThe role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer
Fishman, D. A., Cohen, L., Blank, S. V., Shulman, L., Singh, D., Bozorgi, K., Tamura, R., Timor-Tritsch, I., & Schwartz, P. E. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.01.041 · Cited by 173
Mackenzie, R., Kommoss, S., Winterhoff, B. J. N., Kipp, B. R., García, J. J., Voss, J. S., Halling, K. C., Karnezis, A. N., Senz, J., Yang, W., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1421-8 · Cited by 172
Vang, R., Levine, D. A., Soslow, R. A., Zaloudek, C., Shih, I.-M., & Kurman, R. J. (2016) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000207 · Cited by 170
Self-citationSeidman, J. D., & Khedmati, F. (2008) · Archives of Pathology & Laboratory Medicine · doi:10.5858/132.11.1753 · Cited by 168
Dehari, R., Kurman, R. J., Logani, S., & Shih, I. (2007) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31802cbbe9 · Cited by 168
Self-citationβ- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis
Saegusa, M., Hashimura, M., Yoshida, T., & Okayasu, I. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1581 · Cited by 168
Surface Epithelial Tumors of the Ovary
Seidman, J. D., Cho, K. R., Ronnett, B. M., & Kurman, R. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0489-8_14 · Cited by 168
Self-citationAyhan, A., Mao, T.-L., Seckin, T., Wu, C.-H., Guan, B., Ogawa, H., Futagami, M., Mizukami, H., Yokoyama, Y., Kurman, R. J., et al. (2012) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31826b5dcc · Cited by 167
Self-citationKuhn, E., Meeker, A. K., Wang, T., Sehdev, A. E. S., Kurman, R. J., & Shih, I. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181dcede7 · Cited by 154
Self-citationKurman, R. J., VANG, R. S., Junge, J., Hannibal, C. G., Kjær, S. K., & Shih, I. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318229449f · Cited by 150
Self-citationBRCA1/2-related ovarian cancers are of tubal origin: a hypothesis
Piek, J. M. J., Verheijen, R. H. M., Kenemans, P., Massuger, L. F. A. G., Bulten, H., & van Diest, P. J. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00365-2 · Cited by 147
Jin, Z., Ogata, S., Tamura, G., Katayama, Y., Fukase, M., 矢島, 美., & Motoyama, T. (2003) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000092134.88121.56 · Cited by 136
Alternate molecular genetic pathways in ovarian carcinomas of common histological types
Willner, J. B., Wurz, K., Allison, K. H., Galic, V., Garcia, R. L., Goff, B. A., & Swisher, E. M. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.10.007 · Cited by 135
The Origin of Ovarian Carcinomas: A Unifying Hypothesis
Auersperg, N. (2010) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181f45f3e · Cited by 133
RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary
Ryland, G. L., Hunter, S. M., Doyle, M., Rowley, S. M., Christie, M., Allan, P. E., Bowtell, D. D. L., Chenevix‐Trench, G., Gorringe, K. L., & Campbell, I. (2012) · The Journal of Pathology · doi:10.1002/path.4134 · Cited by 126
Roles of Deletion of Arid1a, a Tumor Suppressor, in Mouse Ovarian Tumorigenesis
Guan, B., Rahmanto, Y. S., Wu, R., Wang, Y., Wang, Z., Wang, T., & Shih, I. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju146 · Cited by 125
Self-citationPohl, G., Ho, C., Kurman, R. J., Bristow, R. E., Wang, T., & Shih, I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3625 · Cited by 123
Self-citationIncidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases
Gilks, C. B., Irving, J., Köbel, M., Lee, C., Singh, N., Wilkinson, N. S., & McCluggage, W. G. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000353 · Cited by 123
Tsang, Y. T. M., Deavers, M. T., Sun, C. C., Kwan, S., Kuo, E., Malpica, A. L., Mok, S. C., Gershenson, D. M., & Wong, K. (2013) · The Journal of Pathology · doi:10.1002/path.4252 · Cited by 119
Emmanuel, C., Chiew, Y.-E., George, J., Etemadmoghadam, D., Anglesio, M. S., Sharma, R. N., Russell, P., Kennedy, C. J., Fereday, S., Hung, J. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1292 · Cited by 118
Evidence for a Dualistic Model of High-grade Serous Carcinoma
Howitt, B. E., Hanamornroongruang, S., Lin, D. I., Conner, J. E., Schulte, S., Horowitz, N. S., Crum, C. P., & Meserve, E. E. K. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000369 · Cited by 111
AOCS Study Group, Köbel, M., Madore, J., Ramus, S. J., Clarke, B. A., Pharoah, P. D. P., Deen, S., Bowtell, D. D. L., Odunsi, K. O., Menon, U., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.567 · Cited by 110
Tang, S., Onuma, K., Deb, P., Wang, E., Lytwyn, A., Sur, M., & Daya, D. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31822ea955 · Cited by 107
Rabban, J. T., Garg, K., Crawford, B., Chen, L.-M., & Zaloudek, C. J. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000199 · Cited by 104
VANG, R. S., Gown, A. M., Barry, T. S., Wheeler, D. T., & Ronnett, B. M. (2005) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000177125.31046.fd · Cited by 100
George, J., Alsop, K., Etemadmoghadam, D., Hondow, H., Mikeska, T., Dobrovic, A., DeFazio, A., Chenevix‐Trench, G., Smyth, G. K., Levine, D. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0066 · Cited by 92
Powell, C. B., Swisher, E. M., Cass, I. A., McLennan, J., Norquist, B. M., Garcia, R. L., Lester, J., Karlan, B. Y., & Chen, L. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.01.029 · Cited by 92
Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers
Mackenzie, R., Talhouk, A., Eshragh, S., Lau, S., Cheung, D., Chow, C., Le, N. D., Cook, L. S., Wilkinson, N., McDermott, J. R., et al. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000476 · Cited by 91
Conner, J., Meserve, E. E. K., Pizer, E. S., Garber, J. E., Roh, M. H., Urban, N. D., Drescher, C. W., Quade, B. J., Muto, M. G., Howitt, B. E., et al. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.12.009 · Cited by 87
Wu, C. H., Mao, T., VANG, R. S., Ayhan, A., Wang, T., Kurman, R. J., & Shih, I. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31823f8482 · Cited by 86
Self-citationKöbel, M., Kalloger, S. E., Lee, S., Duggan, M. A., Kelemen, L. E., Prentice, L., Kalli, K. R., Fridley, B. L., Visscher, D. W., Keeney, G. L., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0391 · Cited by 84
Morrison, J. C., Blanco, L. Z., Vang, R., & Ronnett, B. M. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000352 · Cited by 84
Seromucinous Tumors of the Ovary. What’s in a Name?
Kurman, R. J., & Shih, I. (2015) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000266 · Cited by 79
Self-citationMolecular Characterization of Undifferentiated Carcinoma Associated With Endometrioid Carcinoma
Kuhn, E., Ayhan, A., Bahadirli-Talbott, A., Zhao, C., & Shih, I. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000166 · Cited by 77
Self-citationShvartsman, H. S., Sun, C. C., Bodurka, D. C., Mahajan, V., Crispens, M. A., Lu, K. H., Deavers, M. T., Malpica, A. L., Silva, E. G., & Gershenson, D. M. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.01.030 · Cited by 73
Zeppernick, F. A., Ardighieri, L., Hannibal, C. G., VANG, R. S., Junge, J., Kjær, S. K., Zhang, R., Kurman, R. J., & Shih, I. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000313 · Cited by 69
Self-citationHigh Rates of Occult Fallopian Tube Cancer Diagnosed at Prophylactic Bilateral Salpingo-Oophorectomy
Hirst, J. E., Gard, G. B., McIlroy, K., Nevell, D. F., & Field, M. J. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181a1b5dc · Cited by 67
Kobayashi, Y., Kashima, H., Wu, R., Jung, J.-G., Kuan, J.-C., Gu, J., Xuan, J., Sokoll, L. J., Visvanathan, K., Shih, I., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3368 · Cited by 65
Self-citationEpigenetic determinants of ovarian clear cell carcinoma biology
Yamaguchi, K. D., Huang, Z., Matsumura, N., Mandai, M., Okamoto, T., Baba, T., Konishi, I., Berchuck, A., & Murphy, S. K. (2013) · International Journal of Cancer · doi:10.1002/ijc.28701 · Cited by 59
PAX8 expression in ovarian surface epithelial cells
Adler, E. K., Mhawech-Fauceglia, P. Y., Gayther, S. A., & Lawrenson, K. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.03.017 · Cited by 56
Habis, M., Wroblewski, K., Bradaric, M. J., Ismail, N., Yamada, S. D., Litchfield, L. M., Lengyel, E. R., & Romero, I. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104521 · Cited by 45
Sheu, J. J., Guan, B., Tsai, F., Hsiao, E. Y.-T., Chen, C., Seruca, R., Wang, T., & Shih, I. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.026 · Cited by 42
Self-citationEspinosa, Í., Catasús, L., Canet, B., D′Angelo, E., Muñoz, J., & Prat, J. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.12 · Cited by 33
Loss of p16INK4A Expression in Low-grade Ovarian Serous Carcinomas
Schlosshauer, P. W., Deligdisch, L., Penault-Llorca, F. M., Fatemi, D., Qiao, R., Shen, Y., Pearl, M., Yang, Z., Sheng, T., & Dong, J. (2010) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181ed89b3 · Cited by 18
Kareem, B. N., Karlsen, F., Holm, R., Hennig, E. M., Suo, Z., Emilsen, E., Hellesylt, E., & Nesland, J. M. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199712)183:4<424::aid-path949>3.0.co;2-l · Cited by 4
Research works printed but not linked: 12
- Schmeler, 2010, Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary, Obstet Gynecol, 116, 269, 10.1097/AOG.0b013e3181e7961d · doi:10.1097/aog.0b013e3181e7961d
- Ardighieri, 2014, Shih IeM: Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants, J Pathol, 232, 16, 10.1002/path.4293 · doi:10.1002/path.4293
- Maniar, 2014, Evaluation of microinvasion and lymph node involvement in ovarian serous borderline/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37 cases, Am J Surg Pathol, 38, 743, 10.1097/PAS.0000000000000155 · doi:10.1097/pas.0000000000000155
- Silva, 1990, Ovarian carcinomas with transitional cell carcinoma pattern, Am J Clin Pathol, 93, 457, 10.1093/ajcp/93.4.457 · doi:10.1093/ajcp/93.4.457
- Ardighieri, 2014, Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants, J Pathol, 232, 16, 10.1002/path.4293 · doi:10.1002/path.4293
- Shappell, 2002, Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas, Am J Surg Pathol, 26, 1529, 10.1097/00000478-200212000-00001 · doi:10.1097/00000478-200212000-00001
- Cuatrecasas, 1997, K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases, Cancer, 79, 1581, 10.1002/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T · doi:10.1002/(sici)1097-0142(19970415)79:8<1581::aid-cncr21>3.0.co;2-t
- Wang, 2015, Clonality analysis of combined Brenner and mucinous tumours of the ovary reveals their monoclonal origin, J Pathol, 237, 146, 10.1002/path.4572 · doi:10.1002/path.4572
- Piek, 2001, Tubal ligation and risk of ovarian cancer, Lancet, 358, 844, 10.1016/S0140-6736(01)05992-X · doi:10.1016/s0140-6736(01)05992-x
- Gagner, 2005, Malignant mixed Mullerian tumor of the fimbriated end of the fallopian tube: origin as an intraepithelial carcinoma, Gynecol Oncol, 97, 219, 10.1016/j.ygyno.2004.11.053 · doi:10.1016/j.ygyno.2004.11.053
- Bijron, 2013, Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis, Am J Surg Pathol, 37, 1123, 10.1097/PAS.0b013e318282da7f · doi:10.1097/pas.0b013e318282da7f
- Wethington, 2013, Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC), Int J Gynecol Cancer, 23, 1603, 10.1097/IGC.0b013e3182a80ac8 · doi:10.1097/igc.0b013e3182a80ac8
Cited by
Ovarian cancer statistics, 2018
Torre, L. A., Trabert, B., DeSantis, C. E., Miller, K. D., Samimi, G., Runowicz, C. D., Gaudet, M. M., Jemal, A., & Siegel, R. L. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21456 · Cited by 3,492
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
High grade serous ovarian carcinomas originate in the fallopian tube
Labidi-Galy, S. I., Papp, E., Hallberg, D., Niknafs, N., Adleff, V., Noe, M., Bhattacharya, R., Novak, M., Jones, S., Phallen, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00962-1 · Cited by 759
Self-citationHigh-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Lisio, M.-A., Fu, L., Goyeneche, A., Gao, Z.-H., & Telleria, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040952 · Cited by 680
Cancer-associated mutations in endometriosis without cancer
Anglesio, M. S., Papadopoulos, N., Ayhan, A., Nazeran, T. M., Noë, M., Horlings, H. M., Lum, A., Jones, S., Senz, J., Seckin, T., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614814 · Cited by 628
Self-citation
Metadata
- Authors
- Kurman, R. J., & Shih, I.-M.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 186
- Issue
- 4
- Pages
- 733-747
- ISSN
- 0002-9440 (ISSN-L)
- OpenAlex
- W2305551225
- Cited by
- 923
- References
- 93
- FWCI
- 111.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1351 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.